oxybutynin chloride

Product NDC
70518-3032
11-digit product format
705183032
Labeler code
70518
Product ID
70518-3032_bc7af2a5-f30c-80fb-e053-2995a90a4b79
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
oxybutynin chloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA207138
Marketing category
ANDA
Marketing start
2021-02-26
Marketing end
0000-00-00
Substance
OXYBUTYNIN CHLORIDE
Active strength
5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3032-02023-03-15C16284748780-1f386c64a-49a9-0266-e053-dadaa90a7c1a4d379c05-885a-42b2-ab3a-6bbf8a38a2a5
70518-3032-02023-01-30C16284748780-1f386c64a-49a9-0266-e053-dadaa90a7c1a4d379c05-885a-42b2-ab3a-6bbf8a38a2a5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3032-070518303200100 POUCH in 1 BOX (70518-3032-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-3032-1) 100 pouch2021-02-260000-00-00NoNoCurrent